FDA Law Blog

JANUARY 18, 2022

In October 2014, FDA held a public workshop titled “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3D Printing.” use in education, construction, art, and jewelry). The discussion paper provides an overview of FDA’s current approach to regulation of 3D-printed devices.

Medical 98

Medical Manufacturing Healthcare Government 98

FDA Law Blog

JANUARY 18, 2022

In October 2014, FDA held a public workshop titled “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3D Printing.” use in education, construction, art, and jewelry). The discussion paper provides an overview of FDA’s current approach to regulation of 3D-printed devices.

Medical 75

Medical Manufacturing Healthcare Government 75

Physician's Weekly

JUNE 16, 2025

from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues updated the 2014 policy statement on contraception for adolescents to provide pediatricians with evidence-informed and equity-informed practices in contraceptive care. ” Abstract/Full Text Copyright © 2025 HealthDay.

Patient-Centered 52

Patient-Centered Education Electronics Insurance 52

GeriPal

MARCH 6, 2025

Just out of fellowship, Naheed built a palliative care program for homeless persons called the Palliative Education and Care for the Homeless (PEACH) Program. He’s the founder and leader of the Palliative Education and Care for the Homeless program in Toronto, Palliative care physician at St. Naheed 15:56 2014. Yeah, yeah.

Healthcare 102

Healthcare IT Community Illness 102

GeriPal

DECEMBER 7, 2023

-@AlexSmithMD Additional links: JAMA paper on clinical research risks, climate change, and health Geriatric medicine in the era of climate change Health Care Without Harm: [link] Practice Green Health: [link] Global Consortium for Climate and Health Education: [link] Transcript Eric: Welcome to the GeriPal podcast. This is Eric Widera.

Healthcare 130

Healthcare IT Education Community 130

FDA Law Blog

MAY 26, 2025

Even if otherwise truthful, the promotion of off-label uses of hormones-including through informal campaigns like those conducted by sales reps or under the guise of sponsored continuing medical education courses-run afoul of the FDAs prohibitions on misbranding and mislabeling. 149, 158 (2014). Anthony List v. Driehaus , 573 U.S.

Manufacturing 59

Manufacturing Provider Medical IT 59